Published in Telemedicine Business Week, October 7th, 2009
"A particular HER2 bond on cancer cells, which has a weaker binding affinity than the biotin/avidin interaction, can be identified between TiO2 spheres that are linked to anti-HER2 antibodies and those that are linked to nonspecific mouse IgG antibodies by observing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week